CROWN Study in-Depth: 3 Years Follow Up Data of Lorlatinib in 1st Line ALK+ NSCLC

CROWN Study in-Depth: 3 Years Follow Up Data of Lorlatinib in 1st Line ALK+ NSCLC

last update on: 11/28/2023

Brands

Category

Modules

Lorlak

Oncology

1

Create an account and subscribe